These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20645058)

  • 1. Evaluation of drug metabolism, drug-drug interactions, and in vitro hepatotoxicity with cryopreserved human hepatocytes.
    Li AP
    Methods Mol Biol; 2010; 640():281-94. PubMed ID: 20645058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human hepatocytes: isolation, cryopreservation and applications in drug development.
    Li AP
    Chem Biol Interact; 2007 May; 168(1):16-29. PubMed ID: 17270162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human hepatocytes as an effective alternative experimental system for the evaluation of human drug properties: general concepts and assay procedures.
    Li AP
    ALTEX; 2008; 25(1):33-42. PubMed ID: 18360726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of cryopreserved human hepatocytes as a model system to investigate sulfation and glucuronidation and to evaluate inhibitors of drug conjugation.
    Riches Z; Bloomer J; Patel A; Nolan A; Coughtrie M
    Xenobiotica; 2009 May; 39(5):374-81. PubMed ID: 19280384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism Comparative Cytotoxicity Assay (MCCA) and Cytotoxic Metabolic Pathway Identification Assay (CMPIA) with cryopreserved human hepatocytes for the evaluation of metabolism-based cytotoxicity in vitro: proof-of-concept study with aflatoxin B1.
    Li AP
    Chem Biol Interact; 2009 Apr; 179(1):4-8. PubMed ID: 18950609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of human hepatocytes to investigate drug metabolism and CYP enzyme induction.
    Klieber S; Torreilles F; Guillou F; Fabre G
    Methods Mol Biol; 2010; 640():295-308. PubMed ID: 20645059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance.
    McGinnity DF; Soars MG; Urbanowicz RA; Riley RJ
    Drug Metab Dispos; 2004 Nov; 32(11):1247-53. PubMed ID: 15286053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential.
    Li AP; Lu C; Brent JA; Pham C; Fackett A; Ruegg CE; Silber PM
    Chem Biol Interact; 1999 Jun; 121(1):17-35. PubMed ID: 10418968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro human hepatocyte-based experimental systems for the evaluation of human drug metabolism, drug-drug interactions, and drug toxicity in drug development.
    Li AP
    Curr Top Med Chem; 2014; 14(11):1325-38. PubMed ID: 24805059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of hepatocytes to investigate UDP-glucuronosyltransferases and sulfotransferases.
    Fournel-Gigleux S; Coughtrie MW; Ouzzine M; Magdalou J
    Methods Mol Biol; 2010; 640():309-26. PubMed ID: 20645060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
    Zanelli U; Caradonna NP; Hallifax D; Turlizzi E; Houston JB
    Drug Metab Dispos; 2012 Jan; 40(1):104-10. PubMed ID: 21998403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes.
    Hutzler JM; Yang YS; Albaugh D; Fullenwider CL; Schmenk J; Fisher MB
    Drug Metab Dispos; 2012 Feb; 40(2):267-75. PubMed ID: 22031625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity.
    De Bruyn T; Chatterjee S; Fattah S; Keemink J; Nicolaï J; Augustijns P; Annaert P
    Expert Opin Drug Metab Toxicol; 2013 May; 9(5):589-616. PubMed ID: 23452081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of major in vivo drug metabolic pathways using primary human hepatocytes and HepaRG cells in suspension and a dynamic three-dimensional bioreactor system.
    Darnell M; Ulvestad M; Ellis E; Weidolf L; Andersson TB
    J Pharmacol Exp Ther; 2012 Oct; 343(1):134-44. PubMed ID: 22776955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pivotal role of hepatocytes in drug discovery.
    Soars MG; McGinnity DF; Grime K; Riley RJ
    Chem Biol Interact; 2007 May; 168(1):2-15. PubMed ID: 17208208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human hepatocytes as a tool for studying toxicity and drug metabolism.
    Gómez-Lechón MJ; Donato MT; Castell JV; Jover R
    Curr Drug Metab; 2003 Aug; 4(4):292-312. PubMed ID: 12871046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
    O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
    Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel In Vitro Experimental System for the Evaluation of Drug Metabolism: Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Cryopreserved Human Hepatocytes).
    Li AP; Ho MD; Amaral K; Loretz C
    Drug Metab Dispos; 2018 Nov; 46(11):1608-1616. PubMed ID: 29363498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryopreserved human hepatocytes in suspension are a convenient high throughput tool for the prediction of metabolic clearance.
    Jouin D; Blanchard N; Alexandre E; Delobel F; David-Pierson P; Lavé T; Jaeck D; Richert L; Coassolo P
    Eur J Pharm Biopharm; 2006 Jul; 63(3):347-55. PubMed ID: 16621491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.